4//SEC Filing
Catinazzo Thomas 4
Accession 0000950170-25-011327
CIK 0001812364other
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 9:10 PM ET
Size
11.7 KB
Accession
0000950170-25-011327
Insider Transaction Report
Form 4
Catinazzo Thomas
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-01-29$4.55/sh−2,109$9,596→ 400,222 total - Sale
Common Stock
2025-01-28$4.63/sh−33,753$156,276→ 265,473 total - Sale
Common Stock
2025-01-28$4.63/sh−2,283$10,570→ 263,190 total - Sale
Common Stock
2025-01-30$4.42/sh−20,791$91,896→ 379,431 total - Award
Common Stock
2025-01-28+139,141→ 402,331 total
Footnotes (7)
- [F1]Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 105,723 shares of restricted stock units ("RSUs") on January 27, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
- [F2]Includes 185,775 shares underlying RSUs.
- [F3]The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 15, 2024.
- [F4]Represents RSUs granted to the reporting person pursuant to the Issuer's 2020 Stock Option and Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting.
- [F5]Includes 324,916 shares underlying RSUs.
- [F6]Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 69,570 shares of RSUs on January 29, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
- [F7]Includes 255,346 shares underlying RSUs.
Documents
Issuer
Relay Therapeutics, Inc.
CIK 0001812364
Entity typeother
Related Parties
1- filerCIK 0001818261
Filing Metadata
- Form type
- 4
- Filed
- Jan 29, 7:00 PM ET
- Accepted
- Jan 30, 9:10 PM ET
- Size
- 11.7 KB